Newly recognized syndrome keeps patients from full recovery, researchers say

June 12, 2012

(Medical Xpress) -- University of Florida researchers have identified a medical condition they say keeps many intensive care, heart surgery and burn patients from recovering fully and returning home.

Called persistent inflammation, and catabolism syndrome, or PICS, for short, the newly named condition defies existing treatments and leaves weak and unable to breathe or move properly. Patients generally recover enough from their original illnesses or injuries to be discharged from the hospital, but not enough to return to normal life.

Finding a solution to this enigmatic problem may allow most patients to return to health, and could potentially save billions of dollars in extra each year.

“Hospital mortality is progressively decreasing, but more people are being sent to long-term acute care facilities,” said Dr. Frederick Moore, a professor and chief of acute care surgery in the UF College of Medicine department of surgery. “We’re creating this new population of chronically, critically ill patients.”

Moore and colleagues, including Lyle Moldawer, a professor and vice chairman of research in the department, and Bruce McKinley, a professor of surgery, define and describe the new syndrome in the June 8 edition of the Journal of Trauma and Acute Care Surgery.

In the past, many patients in succumbed to complications such as shock or multiple-organ failure after major or injury and related surgery. Treatment advances now allow most patients to survive those once overwhelming conditions. Still, for many of those patients, PICS is an obstacle to full recovery.

About 250,000 U.S. patients develop PICS each year as a result of severe sepsis, an infection that spreads throughout the body and overwhelms the immune system, the UF researchers estimate. Add to that PICS in other trauma and emergency general surgery patients and the actual number of cases is likely much higher. Extra medical costs associated with intensive and long-term acute care for those patients could reach a $100 billion per year — a conservative estimate — the researchers said.

Moore and colleagues in the departments of surgery and anesthesiology identified the syndrome by analyzing and comparing clinical observations and decades’ worth of immunology research they and others conducted.

The work, funded in part by the National Institute of General Medical Sciences, is the first step toward establishing PICS as a widely recognized condition, the researchers said.

“Further research will be needed to confirm its epidemiology and immune system profile and to identify early predictors so that we can design and study new ways to prevent and treat it,” Moore said.

PICS occurs when the immune system “panics” in response to multiple health threats and releases large numbers of immature immune cells from the bone marrow. These cells have mixed effects on the patient: They cause harmful inflammation and do not protect the body as well as their mature counterparts.

“You have a big surgery that goes fine,” Moore said. “But if you have a complication, and say you develop pneumonia, or an infection at the surgical site, then you have the second hit. It’s this repeated stimulation that causes the bone marrow to release these immature cells.”

Though health care providers usually can help patients avoid major complications such as shock and multiorgan failure, they can’t stop patients’ immune systems from flooding the body with immature immune cells.

Full recovery eludes patients who have PICS because the syndrome drains fuel from the body’s last-resort energy reserve.

“The immune system and all the immune cells require protein and energy and both are coming from structural proteins in the body, such as skeletal muscle,” McKinley said. “Basically, the body is consuming itself.”

Depletion of muscle throughout the body leaves patients increasingly weak, unable to move and breathe well. Replenishing the body with existing nutritional therapies does not coax it to stop cannibalizing its own muscle.

“You can give patients all the good nutrition you have, but their bodies are being told, ‘Break down muscle. Break down muscle.’ That’s what they’re doing,” Moore said.

Medical providers don’t yet know how to treat PICS effectively, but initial attempts to develop successful treatments will build on existing basic therapies and could include special exercise routines and muscle-saving medications. New nutritional therapies that help with wound healing and proper hormone and function could also help the body return to normal.

While researchers seek ways to prevent or effectively treat the syndrome, it continues to inhibit patients’ recovery, with far-reaching negative effects.

“The amount of resources and medical care that’s required by these patients is enormous,” said Dr. Ronald Maier, the Jane and Donald D. Trunkey professor and vice chairman of surgery at the University of Washington. Maier did not contribute to the UF research.

“If we can better understand it, we could then develop therapeutic interventions to minimize it or hopefully help it resolve more quickly.”

Explore further: Researchers to speed up recovery times

Related Stories

Researchers to speed up recovery times

May 3, 2012
Elite athletes and recreational exercisers alike could soon be enjoying quicker recovery times thanks to research into exercise-induced fatigue.

Device helps with Sudden Infant Death Syndrome detection

May 9, 2012
University of Texas at Arlington researchers have obtained a patent for a device aimed at saving babies’ lives through improved and rapid detection of Sudden Infant Death Syndrome.

New tool enhances view of muscles

January 23, 2012
Simon Fraser University associate professor James Wakeling is adding to the arsenal of increasingly sophisticated medical imaging tools with a new signal-processing method for viewing muscle activation details that have never ...

Antibiotics boost risk of infection with antifungal-resistant candida

May 22, 2012
Previous exposure to certain antibiotics could boost the risk of infection with drug-resistant strains of a severe fungal infection. Researchers report their findings in the May 2012 issue of the journal Antimicrobial Agents ...

Equine herpesvirus study to unravel how virus unlocks immune system 'gate'

January 19, 2012
A Colorado State University study will look at how equine herpesvirus type 1 may compromise the immune system immediately upon entering the “gate” of a horse’s respiratory system – the airway and throat ...

Recommended for you

Investigators may unlock mystery of how staph cells dodge the body's immune system

September 21, 2017
For years, medical investigators have tried and failed to develop vaccines for a type of staph bacteria associated with the deadly superbug MRSA. But a new study by Cedars-Sinai investigators shows how staph cells evade the ...

Superbug's spread to Vietnam threatens malaria control

September 21, 2017
A highly drug resistant malaria 'superbug' from western Cambodia is now present in southern Vietnam, leading to alarming failure rates for dihydroartemisinin (DHA)-piperaquine—Vietnam's national first-line malaria treatment, ...

Individualized diets for irritable bowel syndrome better than placebo

September 21, 2017
Patients with irritable bowel syndrome who follow individualized diets based on food sensitivity testing experience fewer symptoms, say Yale researchers. Their study is among the first to provide scientific evidence for this ...

A dose of 'wait-and-see' reduces unnecessary antibiotic use

September 21, 2017
Asking patients to take a 'wait-and-see' approach before having their antibiotic prescriptions filled significantly reduces unnecessary use, a University of Queensland study has shown.

Groundbreaking investigative effort identifies gonorrhea vaccine candidates

September 19, 2017
Researchers at Oregon State University have identified a pair of proteins that show promise as the basis for a gonorrhea vaccine.

Snail fever progression linked to nitric oxide production

September 14, 2017
Bilharzia, caused by a parasitic worm found in freshwater called Schistosoma, infects around 200 million people globally and its advance can lead to death, especially in children in developing countries.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.